Drugs / diphtheria and tetanus toxoids (adsorbed) vaccine
last change Jul 2023 re-read 2 minutes ago

diphtheria and tetanus toxoids (adsorbed) vaccine

Developed for
COVID-19

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05415267 Comparator Jul 2023 → Dec 2026 expected COVID-19 Kirby Institute Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as diphtheria and tetanus toxoids (adsorbed) vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05415267